MedTrace Logo

MK0476 Study in Adult Patients With Acute Asthma (0476-322)

NCT00229970 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 225

Last updated 2022-02-02

Study results available
· View outcomes & findings →

Summary

This study evaluates the efficacy and safety of MK0476 intravenous administration in adult patients with acute asthma.

Conditions

Interventions

DRUG

montelukast sodium

7 mg or 14 mg single injection

DRUG

Comparator: Placebo

Placebo single injection

Sponsors & Collaborators

  • Organon and Co

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2006-10-31
Completion
2007-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00229970 on ClinicalTrials.gov